DeepMed Research

UNIVERSITY OF CALIFORNIA, DAVIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1905-01-01

Employees: 10K

Market Cap: -

Website: http://www.ucdavis.edu

Clinical Trials

Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Solid Tumors

Interventions: Drug: Temsirolimus, Pazopanib

First Posted Date: 2010-02-22

Last Posted Date: 2012-03-28

Lead Sponsor: University of California, Davis

Target Recruit Count: 8

Registration Number: NCT01072890

Locations: 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States

Trial of Minocycline to Treat Children With Fragile X Syndrome

Not Applicable

Completed

Conditions: Fragile X Syndrome

Interventions: Drug: minocycline hydrochloride
Drug: Placebo

First Posted Date: 2010-01-21

Last Posted Date: 2017-05-30

Lead Sponsor: University of California, Davis

Target Recruit Count: 66

Registration Number: NCT01053156

Locations: 🇺🇸
M.I.N.D. Institute at University of California at Davis Medical Center, Sacramento, California, United States

Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin

Completed

Conditions: Dysphagia
Gastroesophageal Reflux

First Posted Date: 2010-01-21

Last Posted Date: 2017-05-30

Lead Sponsor: University of California, Davis

Target Recruit Count: 19

Registration Number: NCT01053286

Locations: 🇺🇸
University of California Davis Medical Center, Sacramento, California, United States

Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation

Not Applicable

Completed

Conditions: Iron Overload
Iron-deficiency Anemia
Oxidative Stress

Interventions: Dietary Supplement: Iron
Dietary Supplement: Placebo

First Posted Date: 2010-01-12

Last Posted Date: 2017-05-30

Lead Sponsor: University of California, Davis

Target Recruit Count: 114

Registration Number: NCT01047098

Locations: 🇺🇸
UC Davis Medical Center, Sacramento, California, United States

Prevention of Overfeeding During Infancy

Phase 2

Completed

Conditions: Obesity

Interventions: Behavioral: Use of baby bottle nipple

First Posted Date: 2010-01-07

Last Posted Date: 2012-08-24

Lead Sponsor: University of California, Davis

Target Recruit Count: 231

Registration Number: NCT01043978

Locations: 🇺🇸
University of California, Davis Medical Center, Sacramento, California, United States

Effects of Vaporized Marijuana on Neuropathic Pain

Phase 1

Completed

Conditions: Neuropathic Pain
Reflex Sympathetic Dystrophy
Peripheral Neuropathy
Post-herpetic Neuralgia
Spinal Cord Injury
Multiple Sclerosis

Interventions: Drug: Mild dose cannabis
Drug: Cannabis
Drug: Low dose cannabis

First Posted Date: 2009-12-21

Last Posted Date: 2018-01-31

Lead Sponsor: University of California, Davis

Target Recruit Count: 44

Registration Number: NCT01037088

Locations: 🇺🇸
CTSC Clinical Research Center, Sacramento VA Medical Center, Sacramento, California, United States

Probiotics in Infants With Cyanotic Congenital Heart Disease

Not Applicable

Completed

Conditions: Cyanotic Congenital Heart Disease

Interventions: Dietary Supplement: Bifidobacterium infantis
Other: Placebo

First Posted Date: 2009-11-23

Last Posted Date: 2014-12-02

Lead Sponsor: University of California, Davis

Target Recruit Count: 12

Registration Number: NCT01018472

Locations: 🇺🇸
UC Davis Children's Hospital, Sacramento, California, United States

Delayed Cord Clamping in Premature Infants

Not Applicable

Terminated

Conditions: Hypothermia
Anemia

Interventions: Other: Delayed cord clamping

First Posted Date: 2009-11-23

Last Posted Date: 2014-12-02

Lead Sponsor: University of California, Davis

Target Recruit Count: 6

Registration Number: NCT01018576

Locations: 🇺🇸
UC Davis Medical Center, Sacramento, California, United States

Letrozole as a Treatment of Endometrial Cancer

Not Applicable

Completed

Conditions: Endometrial Carcinoma

Interventions: Drug: Letrozole

First Posted Date: 2009-10-19

Last Posted Date: 2017-05-30

Lead Sponsor: University of California, Davis

Target Recruit Count: 43

Registration Number: NCT00997373

Locations: 🇺🇸
University of California Davis, Sacramento, California, United States
🇺🇸
University of California, Davis, Sacramento, California, United States

Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy

Not Applicable

Completed

Conditions: Uncontrolled Partial Epilepsy
Ictal Hypoventilation

Interventions: Drug: Placebo
Drug: Fluoxetine

First Posted Date: 2009-09-29

Last Posted Date: 2019-11-27

Lead Sponsor: University of California, Davis

Target Recruit Count: 2

Registration Number: NCT00986310

Locations: 🇺🇸
University of California, Davis, Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy